# RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow

> **NCT05062681** · PHASE4 · UNKNOWN · sponsor: **Cairo University** · enrollment: 60 (estimated)

## Conditions studied

- COVID-19 Pandemic

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT05062681
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-15
- **Primary completion:** 2021-12-15
- **Final completion:** 2022-03-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062681, "RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05062681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*